MCAST COVID-19
Information Page
The health and safety of our community is our top priority. We know that many people are understandably concerned about the current pandemic situation. MCAST is taking increased health and safety measures to address these concerns while ensuring that learning can continue. As the situation continues to develop, please stay updated by visiting mcast.edu.mt/covid19 for the latest information. You can also visit the circulars section for all the official messages sent to staff and students.








- Healthcare-associated infections, a threat to residents of long-term care facilities in Europeby ECDC on May 5, 2025 at 7:31 am
On World Hand Hygiene Day, a new ECDC survey* reveals that 3.1% of the residents in long-term care facilities (LTCFs) had at least one healthcare-associated infection (HAI) at the time of the study.
- Communicable disease threats report, 26 April - 3 May 2025, week 18by ECDC on May 2, 2025 at 3:22 pm
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 April - 3 May 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, SARS-CoV-2, chikungunya virus disease, diphtheria, mpox, influenza A(H5N1), cholera, yellow fever, and Ebola disease.
- The European Respiratory Virus Surveillance Summary (ERVISS)by ECDC on May 2, 2025 at 12:09 pm
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.
- Weekly respiratory virus update, week 17, April 2025by ECDC on May 2, 2025 at 10:48 am
In the EU/EEA, influenza intensity has returned to low levels in most countries and respiratory virus activity is decreasing overall. However, some EU/EEA countries are still affected by ongoing flu and/or RSV epidemics. Preventive measures, such as frequent handwashing, physical distancing, avoiding large gatherings, and wearing masks in healthcare settings can help reduce transmission and protect those at high risk of severe illness.
- Communicable disease threats report, 19 - 25 April 2025, week 17by ECDC on April 25, 2025 at 3:15 pm
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 April 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, influenza, avian influenza, poliomyelitis, and chikungunya virus disease.
News (English) - World Health Organization Corporate news releases, statements, and notes for media issued by the World Health Organization.
- WHO and Medicines Patent Pool announce sublicensing agreement for rapid diagnostic test technologyon May 9, 2025 at 9:11 am
The World Health Organization (WHO) and Medicines Patent Pool (MPP) have today announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start development and manufacturing of rapid diagnostic tests (RDTs) using technology transferred from global in-vitro diagnostics company – SD Biosensor (SDB). This agreement will contribute to advancing equitable access to vital diagnostic tools through local production, expanding manufacturing capacity in the African Region.The new RDT technology is especially useful for low- and middle-income countries (LMICs), as it is easy to use in health facilities without requiring additional equipment. Tests are highly sensitive and can generate results within 20 minutes. Codix Bio will initially focus on producing RDTs for HIV, but the technology can also be used for manufacturing tests for malaria and syphilis, among others. It can also be quickly adapted to other diseases, which will prove valuable during health emergencies and pandemics, contributing to improvements in health security and equity. "Sublicensing SDB’s RDT technology marks a major milestone in strengthening manufacturing capabilities in regions where they are needed most,” said Dr Yukiko Nakatani, WHO Assistant Director-General, Access to Medicines and Health Products. “It can help advance global commitments made at the 2023 World Health Assembly to promote equitable access to diagnostics as a cornerstone of universal health coverage and pandemic preparedness.” “We are delighted to have signed this first sublicense agreement for RDTs with Codix Bio. Today marks a major step forward in diversifying diagnostic production and ensuring access where it is needed most,” said Charles Gore, Executive Director of the Medicines Patent Pool. “It shows how voluntary licensing and coordinated technology transfer can empower manufacturers in LMICs, ultimately helping reshape global supply chains to become more equitable and resilient.” A new beginning for HTAPThis agreement is the first to come out of a non-exclusive, transparent license between SDB and MPP, which was agreed in December 2023 under the auspices of the WHO COVID-19 Technology Access Pool (C-TAP) initiative. C-TAP has since evolved as HTAP – the Health Technology Access Programme, with the goal of reducing the access gap in underserved regions and countries by empowering capable local producers of health products (tests, vaccines, treatments and medical devices) through sublicensing, technology and know-how transfer.“The announcement of this sublicensing agreement with Codix Bio marks an important milestone in our partnership with WHO and MPP. By coupling the technology transfer with coordinated support, this initiative not only helps Codix Bio respond to health priorities in Nigeria and the region – it also demonstrates a collaborative model for building sustainable and self-reliant local manufacturing capacity,” said Hyo-Keun Lee, Vice Chairman of SD Biosensor, Inc. “We are proud that our highly adaptable and reliable rapid diagnostic testing technology will contribute to strengthening regional manufacturing ecosystems and expanding equitable access to diagnostics.” After the WHO and MPP open call was announced for applications for LMIC-based manufacturers, Codix Bio was selected as the first sublicensee. “This landmark agreement is a defining moment in our journey of health-tech innovation and a breakthrough for local healthcare manufacturing in Africa. Being selected as the first sublicensee under this global initiative underscores our commitment to contribute meaningfully to pandemic preparedness and regional health security,” said Sammy Ogunjimi, Group Managing Director/CEO, Codix Group. “With support from WHO and MPP, we are committed to producing high-quality, rapid diagnostic tests that can transform access to timely diagnosis, not just in Nigeria, but across the continent.” HTAP will coordinate support from across WHO and its partners, covering areas such as workforce development, regulatory compliance and product uptake. It is also continuing with evaluations for a potential second sublicensee for this technology transfer.Most LMICs rely on importing health diagnostics. Following fragility and heavy dependence on imported health product supplies during the COVID-19 pandemic and important lessons learnt for regional health security, there is growing momentum for improving local production and supply resilience, including by institutions such as the Africa Centres for Disease Control and Prevention (Africa CDC), the Global Fund and Unitaid."Africa CDC welcomes this partnership as a concrete example of what regional health security can look like. Building diagnostic manufacturing capacity within the continent improves pandemic response and helps build African health sovereignty. We are pleased to see Africa CDC’s strategic direction reflected in this initiative, and we stand ready to support its implementation through coordination and technical assistance,” said Dr Abebe Bayih, lead of the Platform for Harmonized African Health Manufacturing (PHAH). Note to editorsAbout Medicines Patent Pool (MPP)The Medicines Patent Pool (MPP) is a United Nations-backed public health organization working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organizations, industry, patient groups, and other stakeholders to prioritize and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. medicinespatentpool.orgAbout WHODedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int
- Safer walking and cycling crucial for road safety and better healthon May 9, 2025 at 6:51 am
As the 8th UN Global Road Safety Week kicks off around the world under the theme “Make walking and cycling safe,” the World Health Organization (WHO) has launched a new toolkit to help governments promote active mobility – by making it safer.Each year, nearly 1.2 million people lose their lives on the roads, more than a quarter of them while walking or cycling. Yet, only 0.2% of the roads worldwide are equipped with cycle lanes, and far too many communities lack basics like sidewalks or safe pedestrian crossings.“Walking and cycling improve health and make cities more sustainable. Every step and every ride help to cut congestion, air pollution and disease,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “But we must make walking and cycling safe, so more people choose these healthier, greener options.”Despite their benefits, fewer than one-third of countries have national policies to promote walking and cycling. WHO’s new toolkit aims to fill that gap with practical, evidence-based guidance for policymakers, urban planners, health advocates and civil society. The toolkit calls for bold action including: integrating walking and cycling into transport, health, environmental and education policies;building safe infrastructure like sidewalks, crossings and protected cycle lanes;setting and enforcing safer speed limits aligned with global best practices;promoting safe road use through public awareness and behaviour change campaigns; andusing financial incentives to encourage active mobility.While global pedestrian deaths dropped slightly and cyclist deaths plateaued between 2011 and 2021, regional trends show growing danger:In the WHO South-East Asia Region, pedestrian deaths rose by 42%.In the European Region, cyclist deaths surged by 50%.In the Western Pacific Region, cyclist deaths soared by 88%.This week, WHO joins hundreds of organizations and governments worldwide to demand urgent action on road safety. The Global Alliance of NGOs for Road Safety is mobilizing over 400 member organizations in 100 countries to support the campaign.“It is urgent to make, what should be our most natural means of transport, safer. This is paramount for road safety, but also health, equity and climate,” said Etienne Krug, Director of the WHO Department for the Social Determinants of Health. “We’re calling on all sectors – transport, health, education and beyond – to make walking and cycling safe and accessible for everyone.”
- Health inequities are shortening lives by decadeson May 5, 2025 at 4:01 pm
A global report published by the World Health Organization (WHO) highlights that the underlying causes of ill health often stem from factors beyond the health sector, such as lack of quality housing, education and job opportunities.
- WHO at 150th IPU Assembly: elevating health equity and global solidarityon May 2, 2025 at 12:32 pm
"WHO is committed to working with the IPU to inform and support parliaments on global health priorities. We encourage all of you to join your national delegation at WHA78 to make your voice heard and to translate global health decisions into national-level actions," affirmed Dr Tedros in his remarks to the delegates.
- Gloves do not replace hand hygiene – reminder from WHOon May 1, 2025 at 11:51 am
On World Hand Hygiene Day, the WHO emphasizes the critical role of hand hygiene in preventing infections, stating that gloves are not a substitute for proper handwashing.